Mounjaro (Tirzepatide)
4.17 mg/mL · Injection Solution
By Eli Lilly and Company
Tirzepatide · Injectable Solution · 4.17 mg/mL · Subcutaneous
- NDC
- 0002-3466
- Route
- Subcutaneous
- Therapeutic class
- G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist , Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- Marketing category
- NDA
Package sizes
- 1 SYRINGE in 1 CARTON (0002-3466-11) / 2.4 mL in 1 SYRINGE (0002-3466-01)NDC 0002-3466-11Available to Order
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a quote
Request this medication.
Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Diabetes & Endocrine
See all →
Omeosport
Pellet
Guna spa
Available to Source
Guna-Geriatrics
Solution / Drops
Guna spa
Available to Source
Procort (1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream)
18.5 mg/g / 11.5 mg/g · Cream
Womens Choice Pharmaceuticals LLC
Available to Source
1% Hydrocortisone
10 mg/g · Cream
Walmart Inc.
Available to Source